The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support.
It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.
Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E.
age > 18 years old
persistent hemodynamic failure defined as systolic blood pressure of <90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs
patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR)
primary septic, anaphylactic, hypovolemic shock
post-operative cardiogenic shock
end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation
Wroclaw Medical University
Lead sponsor
Polish Cardiac Society
Collaborator
Johnson & Johnson
Collaborator